Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 2/2024

03-01-2024 | Primary Sclerosing Cholangitis | Case Report

An atypical case of isolated immunoglobulin G4-related sclerosing cholangitis with a cholangiogram resembling primary sclerosing cholangitis

Authors: Yoshihisa Takada, Takuya Ishikawa, Kentaro Yamao, Yasuyuki Mizutani, Tadashi Iida, Kota Uetsuki, Hiroki Kawashima

Published in: Clinical Journal of Gastroenterology | Issue 2/2024

Login to get access

Abstract

An asymptomatic 77-year-old man with intrahepatic bile duct dilation was referred to our hospital. Cholangiography revealed alternations between strictures and dilated segments from the right and left hepatic ducts to the lower bile ducts, with findings of a pruned tree, beaded, shaggy appearance, and diverticulum-like outpouching. Histopathology revealed abundant immunoglobulin G4 (IgG4)-positive plasma cells (> 10 per high-power field) with an IgG4/IgG-positive cell ratio of 40–50%. After 2 weeks of steroid therapy, the cholangiography markedly improved. Because the cholangiographic findings resembled those of primary sclerosing cholangitis, steroid therapy proved useful in differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
Literature
1.
go back to reference Culver EL, Chapman RW. IgG4-related hepatobiliary disease: an overview. Nat Rev Gastroenterol Hepatol. 2016;13:601–12.CrossRefPubMed Culver EL, Chapman RW. IgG4-related hepatobiliary disease: an overview. Nat Rev Gastroenterol Hepatol. 2016;13:601–12.CrossRefPubMed
2.
go back to reference Graham RPD, Smyrk TC, Chari ST, et al. Isolated IgG4-related sclerosing cholangitis: a report of 9 cases. Hum Pathol. 2014;45:1722–9.CrossRefPubMed Graham RPD, Smyrk TC, Chari ST, et al. Isolated IgG4-related sclerosing cholangitis: a report of 9 cases. Hum Pathol. 2014;45:1722–9.CrossRefPubMed
3.
go back to reference Kemp W, Majeed A, Mitchell J, et al. Management, outcomes and survival of an Australian IgG4-SC cohort: the MOSAIC study. Liver Int. 2021;41:2934–43.CrossRefPubMed Kemp W, Majeed A, Mitchell J, et al. Management, outcomes and survival of an Australian IgG4-SC cohort: the MOSAIC study. Liver Int. 2021;41:2934–43.CrossRefPubMed
5.
go back to reference Elvevi A, Laffusa A, Scaravaglio M, et al. Clinical treatment of cholangiocarcinoma: an updated comprehensive review. Ann Hepatol. 2022;27:100737.CrossRefPubMed Elvevi A, Laffusa A, Scaravaglio M, et al. Clinical treatment of cholangiocarcinoma: an updated comprehensive review. Ann Hepatol. 2022;27:100737.CrossRefPubMed
6.
go back to reference Naitoh I, Nakazawa T. Endoscopic retrograde cholangiopancreatography and intraductal ultrasonography in the diagnosis of autoimmune pancreatitis and IgG4-related sclerosing cholangitis. J Med Ultrason. 2021;48:573–80.CrossRef Naitoh I, Nakazawa T. Endoscopic retrograde cholangiopancreatography and intraductal ultrasonography in the diagnosis of autoimmune pancreatitis and IgG4-related sclerosing cholangitis. J Med Ultrason. 2021;48:573–80.CrossRef
7.
go back to reference Nakazawa T, Kamisawa T, Okazaki K, et al. Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020: (revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012). J Hepatobiliary Pancreat Sci. 2021;28:235–42.CrossRefPubMed Nakazawa T, Kamisawa T, Okazaki K, et al. Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020: (revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012). J Hepatobiliary Pancreat Sci. 2021;28:235–42.CrossRefPubMed
8.
go back to reference Matsumoto R, Miura S, Kanno A, et al. IgG4-related sclerosing cholangitis mimicking cholangiocarcinoma diagnosed by endoscopic ultrasound-guided fine-needle aspiration. Intern Med. 2020;59:945–50.CrossRefPubMed Matsumoto R, Miura S, Kanno A, et al. IgG4-related sclerosing cholangitis mimicking cholangiocarcinoma diagnosed by endoscopic ultrasound-guided fine-needle aspiration. Intern Med. 2020;59:945–50.CrossRefPubMed
9.
go back to reference Naitoh I, Kamisawa T, Tanaka A, et al. Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: comparison of cases with and without autoimmune pancreatitis in a large cohort. Dig Liver Dis. 2021;53:1308–14.CrossRefPubMed Naitoh I, Kamisawa T, Tanaka A, et al. Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: comparison of cases with and without autoimmune pancreatitis in a large cohort. Dig Liver Dis. 2021;53:1308–14.CrossRefPubMed
10.
go back to reference Naitoh I, Nakazawa T, Ohara H, et al. Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis. J Gastroenterol. 2009;44:1147–55.CrossRefPubMed Naitoh I, Nakazawa T, Ohara H, et al. Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis. J Gastroenterol. 2009;44:1147–55.CrossRefPubMed
11.
go back to reference Tanaka A. IgG4-related sclerosing cholangitis and primary sclerosing cholangitis. Gut Liver. 2019;13:300.CrossRefPubMed Tanaka A. IgG4-related sclerosing cholangitis and primary sclerosing cholangitis. Gut Liver. 2019;13:300.CrossRefPubMed
12.
go back to reference Nakazawa T, Ohara H, Sano H, et al. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas. 2006;32:229.CrossRefPubMed Nakazawa T, Ohara H, Sano H, et al. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas. 2006;32:229.CrossRefPubMed
13.
go back to reference Naitoh I, Nakazawa T, Hayashi K, et al. Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and IgG4-related sclerosing cholangitis. J Gastroenterol Hepatol. 2015;30:1104–9.CrossRefPubMed Naitoh I, Nakazawa T, Hayashi K, et al. Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and IgG4-related sclerosing cholangitis. J Gastroenterol Hepatol. 2015;30:1104–9.CrossRefPubMed
14.
go back to reference Itoi T, Kamisawa T, Igarashi Y, et al. The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis. J Gastroenterol. 2013;48:504–14.CrossRefPubMed Itoi T, Kamisawa T, Igarashi Y, et al. The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis. J Gastroenterol. 2013;48:504–14.CrossRefPubMed
15.
go back to reference Navaneethan U, Hasan MK, Lourdusamy V, et al. Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review. Gastrointest Endosc. 2015;82:608.CrossRefPubMedPubMedCentral Navaneethan U, Hasan MK, Lourdusamy V, et al. Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review. Gastrointest Endosc. 2015;82:608.CrossRefPubMedPubMedCentral
16.
go back to reference Lübbe J, Arnelo U, Lundell L, et al. ERCP-guided cholangioscopy using a single-use system: nationwide register-based study of its use in clinical practice. Endoscopy. 2015;47:802–7.CrossRefPubMed Lübbe J, Arnelo U, Lundell L, et al. ERCP-guided cholangioscopy using a single-use system: nationwide register-based study of its use in clinical practice. Endoscopy. 2015;47:802–7.CrossRefPubMed
17.
go back to reference Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706–15.CrossRefPubMed Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706–15.CrossRefPubMed
18.
go back to reference Kawakami H, Zen Y, Kuwatani M, et al. IgG4-related sclerosing cholangitis and autoimmune pancreatitis: histological assessment of biopsies from Vater’s ampulla and the bile duct. J Gastroenterol Hepatol. 2010;25:1648–55.CrossRefPubMed Kawakami H, Zen Y, Kuwatani M, et al. IgG4-related sclerosing cholangitis and autoimmune pancreatitis: histological assessment of biopsies from Vater’s ampulla and the bile duct. J Gastroenterol Hepatol. 2010;25:1648–55.CrossRefPubMed
19.
go back to reference Navaneethan U, Njei B, Lourdusamy V, et al. Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2015;81:168.CrossRefPubMed Navaneethan U, Njei B, Lourdusamy V, et al. Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2015;81:168.CrossRefPubMed
20.
go back to reference Aoki T, Ohno E, Ishikawa T, et al. Endoscopic sphincterotomy and endoscopic biliary stenting do not affect the sensitivity of transpapillary forceps biopsy for the diagnosis of bile duct adenocarcinoma. BMC Gastroenterol. 2022;22:329.CrossRefPubMedPubMedCentral Aoki T, Ohno E, Ishikawa T, et al. Endoscopic sphincterotomy and endoscopic biliary stenting do not affect the sensitivity of transpapillary forceps biopsy for the diagnosis of bile duct adenocarcinoma. BMC Gastroenterol. 2022;22:329.CrossRefPubMedPubMedCentral
21.
go back to reference Kawashima H, Ohno E, Ishikawa T, et al. Endoscopic management of perihilar cholangiocarcinoma. Dig Endosc. 2022;34:1147–56.CrossRefPubMed Kawashima H, Ohno E, Ishikawa T, et al. Endoscopic management of perihilar cholangiocarcinoma. Dig Endosc. 2022;34:1147–56.CrossRefPubMed
22.
go back to reference Yamamoto K, Tsuchiya T, Itoi T, et al. Evaluation of novel slim biopsy forceps for diagnosis of biliary strictures: single-institutional study of consecutive 360 cases (with video). World J Gastroenterol. 2017;23:6429–36.CrossRefPubMedPubMedCentral Yamamoto K, Tsuchiya T, Itoi T, et al. Evaluation of novel slim biopsy forceps for diagnosis of biliary strictures: single-institutional study of consecutive 360 cases (with video). World J Gastroenterol. 2017;23:6429–36.CrossRefPubMedPubMedCentral
23.
go back to reference Kubota K, Kamisawa T, Nakazawa T, et al. Steroid therapy still plays a crucial role and could serve as a bridge to the next promising treatments in patients with IgG4-related sclerosing cholangitis: results of a Japanese Nationwide Study. J Hepatobiliary Pancreat Sci. 2022;29:884–97.CrossRef Kubota K, Kamisawa T, Nakazawa T, et al. Steroid therapy still plays a crucial role and could serve as a bridge to the next promising treatments in patients with IgG4-related sclerosing cholangitis: results of a Japanese Nationwide Study. J Hepatobiliary Pancreat Sci. 2022;29:884–97.CrossRef
25.
go back to reference Moon SH, Kim MH, Lee JK, et al. Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis. J Gastroenterol. 2017;52:483–93.CrossRefPubMed Moon SH, Kim MH, Lee JK, et al. Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis. J Gastroenterol. 2017;52:483–93.CrossRefPubMed
26.
go back to reference Iwasaki S, Kamisawa T, Koizumi S, et al. Assessment in steroid trial for IgG4-related sclerosing cholangitis. Adv Med Sci. 2015;60:211–5.CrossRefPubMed Iwasaki S, Kamisawa T, Koizumi S, et al. Assessment in steroid trial for IgG4-related sclerosing cholangitis. Adv Med Sci. 2015;60:211–5.CrossRefPubMed
27.
go back to reference Tomiyama T, Uchida K, Matsushita M, et al. Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis. J Gastroenterol. 2011;46:696–704.CrossRefPubMed Tomiyama T, Uchida K, Matsushita M, et al. Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis. J Gastroenterol. 2011;46:696–704.CrossRefPubMed
28.
go back to reference Ikeura T, Tomiyama T, Takaori A, et al. Long-term outcomes after steroid pulse therapy in patients with type 1 autoimmune pancreatitis. Intern Med. 2023;15(62):2931–40.CrossRef Ikeura T, Tomiyama T, Takaori A, et al. Long-term outcomes after steroid pulse therapy in patients with type 1 autoimmune pancreatitis. Intern Med. 2023;15(62):2931–40.CrossRef
29.
go back to reference Kamisawa T, Nakazawa T, Tazuma S, et al. Clinical practice guidelines for IgG4-related sclerosing cholangitis. J Hepatobiliary Pancreat Sci. 2019;26:9.CrossRefPubMedPubMedCentral Kamisawa T, Nakazawa T, Tazuma S, et al. Clinical practice guidelines for IgG4-related sclerosing cholangitis. J Hepatobiliary Pancreat Sci. 2019;26:9.CrossRefPubMedPubMedCentral
30.
go back to reference Cho SH, Song TJ, Park J-S, et al. Comparison of the long-term outcomes between proximal and distal IgG4-related sclerosing cholangitis: a multicenter cohort study. J Gastroenterol Hepatol. 2023;38:648–55.CrossRefPubMed Cho SH, Song TJ, Park J-S, et al. Comparison of the long-term outcomes between proximal and distal IgG4-related sclerosing cholangitis: a multicenter cohort study. J Gastroenterol Hepatol. 2023;38:648–55.CrossRefPubMed
31.
go back to reference Song J, Li Y, Bowlus CL, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis (PSC): a comprehensive review. Clin Rev Allergy Immunol. 2020;58:134–49.CrossRefPubMed Song J, Li Y, Bowlus CL, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis (PSC): a comprehensive review. Clin Rev Allergy Immunol. 2020;58:134–49.CrossRefPubMed
32.
go back to reference Trilianos P, Agnihotri A, Ucbilek E, et al. Greater biosynthetic liver dysfunction in primary sclerosing cholangitis suggests co-existent or impending cholangiocarcinoma. J Clin Transl Hepatol. 2016;4:1–4.PubMedPubMedCentral Trilianos P, Agnihotri A, Ucbilek E, et al. Greater biosynthetic liver dysfunction in primary sclerosing cholangitis suggests co-existent or impending cholangiocarcinoma. J Clin Transl Hepatol. 2016;4:1–4.PubMedPubMedCentral
33.
go back to reference Villard C, Friis-Liby I, Rorsman F, et al. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis. J Hepatol. 2023;78:604–13.CrossRefPubMed Villard C, Friis-Liby I, Rorsman F, et al. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis. J Hepatol. 2023;78:604–13.CrossRefPubMed
34.
go back to reference Hirano K, Tada M, Sasahira N, et al. Incidence of malignancies in patients with IgG4-related disease. Intern Med. 2014;53:171–6.CrossRefPubMed Hirano K, Tada M, Sasahira N, et al. Incidence of malignancies in patients with IgG4-related disease. Intern Med. 2014;53:171–6.CrossRefPubMed
35.
go back to reference Tanaka A, Tazuma S, Okazaki K, et al. Clinical features, response to treatment, and outcomes of IgG4-related sclerosing cholangitis. Clin Gastroenterol Hepatol. 2017;15:920-926.e3.CrossRefPubMed Tanaka A, Tazuma S, Okazaki K, et al. Clinical features, response to treatment, and outcomes of IgG4-related sclerosing cholangitis. Clin Gastroenterol Hepatol. 2017;15:920-926.e3.CrossRefPubMed
Metadata
Title
An atypical case of isolated immunoglobulin G4-related sclerosing cholangitis with a cholangiogram resembling primary sclerosing cholangitis
Authors
Yoshihisa Takada
Takuya Ishikawa
Kentaro Yamao
Yasuyuki Mizutani
Tadashi Iida
Kota Uetsuki
Hiroki Kawashima
Publication date
03-01-2024
Publisher
Springer Nature Singapore
Published in
Clinical Journal of Gastroenterology / Issue 2/2024
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-023-01903-w

Other articles of this Issue 2/2024

Clinical Journal of Gastroenterology 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.